Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00368732 · ClinicalTrials.gov registry record
Genetic and Nutritional Causes of Heart Birth Defects
A clinical trial of Heart Defects, Congenital, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 1,610
- Enrollment target
- 1
- Study location
NCT00368732 is a study of Heart Defects, Congenital that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 1,610 participants, above the 185-participant average among 9 other Heart Defects, Congenital trials with a reported enrollment target (770% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00368732, a study of Heart Defects, Congenital, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 1,610 participants
- Enrollment target
- 1
- Study location
Study Summary
Each year in the United States, thousands of babies are born with heart defects. Women who take folic acid during pregnancy have a lower risk of giving birth to infants with heart defects, but the reason for this remains unknown. This study will examine the relationship between genes, nutrition, and the occurrence of heart defects in infants.
Conditions Studied
Study Locations (1)
California
- California Birth Defects Monitoring Program - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,610 participants |
| Start Date | 2006-07 |
| Est. Completion | 2006-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00368732
The ClinicalTrials.gov registry entry for NCT00368732 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,610 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 185-participant average among 9 other Heart Defects, Congenital trials with a reported enrollment target (770% higher). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Defects, Congenital appearing as the primary indexed condition, and to 0 interventions.
NCT00368732 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00368732 about?
NCT00368732 is a clinical study titled "Genetic and Nutritional Causes of Heart Birth Defects". Each year in the United States, thousands of babies are born with heart defects. Women who take folic acid during pregnancy have a lower risk of giving birth to infants with heart defects, but the reason for this remains unknown. This study will examine the relationship between genes, nutrition, and...
What is the current status of trial NCT00368732?
This trial is currently completed. The enrollment target is 1,610 participants. The study started on 2006-07. Estimated completion is 2006-12.
What conditions does trial NCT00368732 study?
This clinical trial studies the following conditions: Heart Defects, Congenital.
Who is sponsoring clinical trial NCT00368732?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00368732 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Defects, Congenital
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
RECRUITING · NA
-
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
RECRUITING · Phase 2
-
Congenital Heart Disease Physical Activity Lifestyle Study V.2
RECRUITING · NA
-
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
ACTIVE NOT RECRUITING · NA
-
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
ACTIVE NOT RECRUITING · NA
-
Comparison of Hematocrit Levels in Infant Heart Surgery
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.